RSS

Editor's Desk

Reece Armstrong looks forward to Christmas in the only we he can - by comparing politics and pharma. Read more

News

Reece Armstrong writes about Brexit's impact on pharma one last time and looks ahead to CPhI Worldwide. Read more

News

EPM editor Reece Armstrong examines the consequences of faulty data for a well-known pharma company. Read more

Opinion

EPM editor Reece Armstrong flies the flag for the LGBT+ community working within life sciences. Read more

Opinion

European Pharmaceutical Manufacturer editor Reece Armstrong examines both sides of the argument relating to the world's most expensive drug. Read more

Opinion

EPM editor Reece Armstrong writes why international efforts are essential for global health concerns like AMR and vaccination. Read more

Opinion

Reece Armstrong examines Scott Gottlieb's legacy on the FDA and what it means for pharmaceutical manufacturers. Read more

Latest Issue

Reece Armstrong examines the looming possibility of a 'no deal' Brexit and why the industry is entering the golden age of innovation. Read more

Opinion

With the potential of antimicrobial resistance (AMR) taking our modern medicine practices back to the stone age, governments around the world need to face the threat head on. Read more

Opinion

In his first Editor's Desk focus, Reece Armstrong asks whether it's time pharmaceutical manufacturers change their approaches to the way drugs are developed, in response to changing healthcare needs around the world. Read more

Latest Issue

Jonathan Gaik, director, Natoli Scientific, offers a stepwise approach to pharmaceutical manufacturers looking to optimise their tablet formulation strategy. Read more

Latest Issue

In her last Editor's Desk feature, Felicity Thomas analyses how Brexit is going to affect the pharma industry and what we can expect from the EMA and MHRA. Read more

News

Taking Prime position.jpg

Mila Dubas / Shutterstock.com

As the pharma market is rocked by the news of Amazon’s acquisition of PillPack — the online pharmacy — we briefly take a look at the history of the e-commerce giant and what impact its move into pharma may have on the traditional space. Read more

Opinion

With worldwide orphan drug sales predicted to grow at a significant rate and each drug fetching a hefty price tag, I look at this market and its drivers in a bit more detail… Read more

Opinion

As the race to dominate the artificial intelligence (AI) space steps up a gear, I take a look at how AI finds use in pharma and how different regions plan to invest in this exciting area. Read more

Opinion

Despite the ongoing trend in digital tech across the board, pharma is still lagging behind in unlocking the potential of these useful tools… Read more

Opinion

With recent plans announced by the UK’s prime minister to remain part of the EMA, which would be favourable for many in the pharma industry, I will look at these developments as well as how they will impact industry and the reactions from leaders Read more

Opinion

As we embark on a difficult flu season, I look at why infection rates vary so much year on year and the potential universal vaccine one company is progressing through the clinical development stages. Read more

Opinion

Oral solid dosage forms are still the preferred method of delivery for the pharma industry but what challenges are encountered and how does the industry solve these potential problems? Read more

Opinion

If you are considering a quick winter getaway or some last minute sunshine over the festive period, make sure you check your meds or you may get more than you bargain for… Read more

Opinion